Tatva Chintan Pharma Chem Submits FY26 BRSR Report

Tatva Chintan Pharma Chem Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as required by SEBI Listing Regulations. The report, which forms part of the Annual Report, is available on the company's website. The BRSR details the company's corporate identity, business activities in specialty chemicals (98.94% of turnover), products like Structure Directing Agents (40.74%), Phase Transfer Catalysts (23.12%), and Pharmaceutical/Agrochemical Intermediates (33.05%). It also outlines operations across 17 states nationally and 30 countries internationally, with exports contributing 75% of turnover. Employee data, including 363 permanent employees and 734 permanent workers, is provided, along with details on differently-abled personnel and gender representation on the Board (16.67% female) and Key Management Personnel (0% female). The reporting is on a standalone basis.